Exhibit 107
Calculation of Filing Fee Table
Form S-1
(Form Type)
Allarity Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Unit | Maximum Aggregate Offering Price(1)(2) | Fee Rate | Amount of Registration Fee | |||||||||||||||||||
| Fees to be paid | Equity | Common Stock, par value $0.0001 per share (the “Common Stock”)(3) | Rule 457(o) | — | — | $ | 10,000,000 | 0.0001102 | $ | 1,102.00 | ||||||||||||||||
Equity | Pre-Funded Warrants to purchase shares of Common Stock (“Pre-Funded Warrants”)(3)(4) | Rule 457(g) | — | — | — | — | — | |||||||||||||||||||
Equity | Common Stock Purchase Warrants to purchase shares of Common Stock (“Common Warrants”)(4) | Rule 457(g) | — | — | $ | 10,000,000 | 0.0001102 | $ | 1,102.00 | |||||||||||||||||
| Equity | Common Stock issuable upon exercise of the Common Warrants | Rule 457(o) | — | — | — | — | — | |||||||||||||||||||
| Equity | Common Stock issuable upon exercise of the Prefunded Warrants | Rule 457(o) | — | — | — | — | — | |||||||||||||||||||
| Total Offering Amount | $ | 20,000,000 | $ | 2,204.00 | ||||||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||||
| Net Fee Due | $ | 2,204.00 | ||||||||||||||||||||||||
| (1) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder include such indeterminate number of additional shares of common stock as may be issued after the date hereof as a result of stock splits, stock dividends or similar transactions. |
| (2) | Estimated solely for the purpose of calculating the registration fee pursuant Rule 457(o) under the Securities Act. |
| (3) | The proposed maximum aggregate offering price of the shares of Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the aggregate offering price of the Pre-Funded Warrants offered and sold in the offering (plus the aggregate exercise price of the shares of common stock issuable upon exercise of the Pre-Funded Warrants), and as such the proposed aggregate maximum offering price of the shares of Common Stock and Pre-Funded Warrants (including shares of Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $10,000,000. |
| (4) | No separate fee is required pursuant to Rule 457(g) under the Securities Act. |
